Aims Risk-stratification of asymptomatic Brugada Syndrome (BS) patients remains a key-issue. A typical spontaneous BS-ECG pattern and ventricular tachycardia (VT)/ ventricular fibrillation (VF) inducibility are two recognized risk markers. The aim of the study was to identify additional risk markers in asymptomatic BS.
ventricular arrhythmia. 2, 3 The ST-SE is influenced by the autonomic system and could be increased by an increased vagal tone before the arrhythmic event. [4] [5] [6] Nocturnal predominance of the arrhythmic events 7, 8 and a possible presynaptic sympathetic denervation 9, 10 are also clues in favour of a role of the autonomic nervous system in the BS.
Patients with BS rescued from sudden cardiac death have a high risk of recurrence. A new arrhythmic event occurs in 62% of the subjects. 11 The high recurrence rate justifies the use of automatic implantable defibrillators as no effective drug therapy has been found. Identification of BS in growing number of asymptomatic patients or relatives becomes critical. Risk-stratification includes typical spontaneous BS-ECG and ventricular tachycardia (VT)/ventricular fibrillation (VF) inducibility. According to Brugada, 17% of asymptomatic patients with such markers will have an arrhythmic event during a mean follow-up of 27 months and should be preventively implanted with a defibrillator. 11 However, the potential benefit of such treatment is not clearly demonstrated in asymptomatic patients. Improvement of the riskstratification in asymptomatic patients appears a key-issue.
To identify additional risk markers in asymptomatic BS, we conducted a study comparing Holter monitoring between symptomatic and asymptomatic patients. Heart rate variability (HRV), QT-interval rate-dependence and dispersion as well as the extent and magnitude of ST-SE were investigated with a special concern on the diurnal and nocturnal periods of the recordings.
Method
Study population (Table 1) The BS population followed in our institutions (CHU d'Amiens and Hôpital Lariboisière, Paris) includes 106 patients. Symptomatic VT/VFs were documented in 13 cases and unexplained syncope in 13. Among the 80 asymptomatic patients, an electrophysiological study was performed in 68 cases. A VT/VF was inducible in 40 and not inducible in 28 patients.
From this cohort, 47 patients had both a drug-free Holter recording and a programmed ventricular stimulation. They form the basis of this study (Male=36, mean age=45±13 years). Symptomatic patients (n=21) were defined as those having a history of cardiac events including cardiac arrests, malignant ventricular arrhythmias and syncope. Cardiac arrest or malignant ventricular arrhythmia occurred in 11 patients and unexplained syncope in 10 patients. Symptoms appeared during the diurnal period in 12 cases and in the nocturnal period in nine patients. The 26 asymptomatic BS were relatives of patients or had been diagnosed by chance. Patients had typical spontaneous BS-ECGs in 21 cases and drug-induced BS-ECGs in 26 cases. SCN5A mutations were identified in 12 out of the 21 patients who were genotyped.
Brugada Syndrome was diagnosed in accordance with the current diagnosis criteria. 12 In symptomatic patients or subjects with a familial history of BS, diagnosis was based on a coved-type ST-SE in more than one right precordial lead (V1-V3) in the presence or absence of a Na channel blocker. In asymptomatic patients with saddle-type ECG, a >0.2 mv drug-induced coved ST-SE in right precordial leads was required. The absence of structural heart disease was verified by non invasive and invasive investigations including 2D echocardiography, magnetic resonance imagining (MRI) and coronary angiography with right and left ventricular angiography when appropriate. A typical spontaneous BS-ECG was defined by the presence of, at least, one coved-type ECG recording. Na channel blockade challenge was carried out in the other cases with intravenous infusion of ajmaline (1 mg/kg/s) to confirm the diagnosis of BS. During the tests, ECGs were monitored on a computerized electrophysiological system and stored on optical disks. Na channel blockade challenge was regarded as positive if a >0.2 mV down-sloping ST-SE measured 20 ms after the end of the QRS was detected in the right precordial lead including V1 and V2 recorded in the 2nd intercostal space.
3,13

Holter monitoring
Digital Holter ECGs were recorded on PCMCIA flash cards and analysed with the SyneTec software (ELA medical, F-Le PlessisRobinson). The A/D sampling rate of the Holter system is 200 Hz with an 8-bit resolution. Extrasystoles and artefacts were removed from analysis.
Heart rate variability
The following HRV parameters were measured: standard deviation of all the NN intervals (SDNN), standard deviation of 5 min averaged NN intervals: (SDANN), root mean squared of successive difference of NN intervals: (rMSSD), percentage of NN intervals over 50 ms: (pNN50) in time domain and, high frequency: 0.15-0.40 Hz (HF), low frequency: 0.04-0.15 Hz (LF) and very low frequency: 0.003-0.04 (VLF) components in frequency domain. Heart rate variability frequency domain was computed using a fast Fourier transform on 256 s periods. A Hanning window was used to limit border effects. Ultra low frequency (ULF) band which by definition reflects fluctuations occurring every 5 min to every 24 h was not measured directly because the software is designed to perform spectral analysis on period <5 min. Ultra low frequency component was calculated with an alternative method by subtracting the total value of VLF, LF and HF bands from the total spectral power.
14 Total spectral power was obtained by measuring the total variance of the RR-intervals.
QT-interval analysis
A mean complex waveform based on 30 s of ECG was calculated by the software by synchronizing the onset of the QRS. The peak of the T wave was individualized using the parabola method (QT apex). The end of the T wave was determined by the intersection between the maximum decreasing tangent and the isoelectric line (QT end). The accuracy of the apex and end of T wave location was verified visually before data computing. Corrected QT apex (QTac) and corrected QT end (QTec) were calculated with the Bazett formula. As well, QTa/RR slopes, QTe/RR slopes and QT-interval dispersions between the recorded leads were automatically computed for the 24 hours and for the diurnal and nocturnal periods. By default, the diurnal and nocturnal periods were set between 8:00-21:00h and 23:00-06:00h. Adjustments with sleeping periods were performed when necessary according to the patient's diary.
ST-SE analysis
ST-segment elevation was investigated over the 24 h. The isoelectric line 25 ms before the onset of QRS was chosen as a reference. Presence of a ST-SE episode was defined as at least >1 min BS-ECG episode. ST-segment elevation was measured 20 ms after the end of the QRS. Relative duration of ST-SE over the length of the recording was quantified for the levels of >0.2 mV and >0.1 mV. All the ST-SE episodes were controlled visually. Permanent ST-SE was arbitrarily defined as the presence of a >0.1 mV ST-SE during more than 80% of the total Holter monitoring length.
Electrophysiologic study
Electrophysiologic study was carried out with a standardized protocol including a driving cycle length of 600 and 400 ms, up to three extra stimuli and with a shortest coupling interval of 200 ms. Both right ventricular apex and outflow tract, were paced at twice the right ventricular diastolic threshold. Ventricular tachycardia/ventricular fibrillation inducibility was defined as induction of monomorphic or polymorphic ventricular tachycardia lasting >20 s or degenerating into ventricular fibrillation.
Statistical analysis
Variables were expressed as mean±standard deviation. Comparisons between groups were performed with the chi-squared test and with the Mann-Witney U non-parametric test. Repeated values were compared with paired t tests. Correlations between qualitative variables were estimated by the contingency coefficient. A bilateral P value under 0.05 was considered as significant.
A binary logistic regression model was used in order to estimate the Holter variables which influenced the symptomatic condition in BS. The two usual risk-markers of symptomatic BS (VT/VF inducibility and presence of a typical spontaneous BS-ECG) and Holter data which were significantly different between symptomatic and asymptomatic BS patients in univariate analysis were included into the binary logistic regression. Data were included when the P value was <0.1. A forward stepwise (Wald) procedure was used. All the statistical analyses were performed with the SPSS software 9.0.
Results
Asymptomatic and symptomatic groups were comparable in clinical variables including age, sex ratio, body mass indexes, mean Holter duration and condition of recording. The amount of familial BS was higher in asymptomatic patients (Table 1) . Table 2 and Table 3) Mean 24 h RR-interval, diurnal and nocturnal RR-intervals were similar in symptomatic and in asymptomatic patients. A downward trend of all the time domain variables of HRV, especially during the nocturnal period and a significant reduction of the nocturnal SDANN (46±13 vs 57±18 ms vs P=0.02) were found in symptomatic vs. asymptomatic patients. Ultra low frequency was significantly lower during the night in symptomatic versus asymptomatic patients(3287±2312 vs 5030±3270 ms 2 , P=0.04) while LF/HF ratio and VLF were not different between the two groups.
HRV (
QT-interval rate-dependence and dispersion
A loss of the normal circadian modulation of QT ratedependence was evidenced with disappearance of the normal difference between diurnal and nocturnal values of the QTa/RR or QTe/RR slopes in the two groups of patients (Table 4) . Comparison between the group of symptomatic and asymptomatic BS did not disclose significant differences in QTa/RR or QTe/RR slopes, in corrected QTa-intervals (313±26 vs 312±30 ms) and corrected QTe-intervals (398±32 vs 394±37 ms), or in QTa dispersion (10±7 vs 13±15 ms) and QTe dispersion (12±6 vs 20±23 ms).
Characteristics of ST-SE (Table 5)
Holter including at least one right precordial lead for appropriate ST-segment analysis were available in 87% (41/47) of the patients. The presence of ST-SE as well as its >0.2 mV or >0.1 mV relative extent over the 24 h were not different between the symptomatic and the asymptomatic patients. ST-segment elevation episodes were more frequent during nocturnal period (Fig. 1 ) than during diurnal period (22/32, 69% vs 10/32, 31%, P=0.03) without any difference between the two groups of patients. There was no correlation between the timing of the clinical events and the nyctemeral distribution of the ST-SE or between the permanent feature of the ST-SE and the presence of a typical spontaneous BS-ECG. Permanent ST-SE was observed in 23.8% of the typical spontaneous BS-ECG and in 15.4% of the cases of Brugadacompatible ECG (NS). Typical spontaneous BS-ECG, VT/VF inducibility, nocturnal SDANN, nocturnal Ultra low frequency and nocturnal SDNN were entered into a binary logistic regression model using a stepwise procedure. Ventricular tachycardia/ventricular fibrillation inducibility, a typical spontaneous BS-ECG and a low nocturnal SDANN were independently associated with cardiac events. The overall model was significant at the 0.003 level according to the model chi-square statistic. The odds ratio of cardiac events increased by 65% each time the SDANN decreased by 10 ms, assuming that inducibility and ECG pattern are held constant (Table 6 ). Combining a SDANN <50 ms to a spontaneous BS-ECG and VT/VF inducibility increases specificity from 85% to 96% with a sensitivity of 52%; the positive and negative predictive values varying respectively from 78% to 92% and from 76% to 71%.
Risk markers for cardiac events in BS
Discussion
The main result of this study is identification of a decreased nocturnal SDANN and ULF in patients with symptomatic BS. The decrease in nocturnal SDANN was independent of the two markers used for risk stratification: a typical spontaneous BS-ECG and VT/VF inducibility. 11, 15 We also evidenced a loss of QT/RR slopes circadian modulation in both symptomatic and asymptomatic BS. Frequent variations of the ST-SE were detected during the Holter recordings with a nocturnal predominance of those variations. The nyctemeral distribution of ST-SE was not correlated with the timing of the arrhythmic events.
Decreased nocturnal SDANN and nocturnal ULF in symptomatic patients with BS
A defined part of HRV reflects the input of the autonomous nervous system on the sinus node. High frequency component of spectral analysis and time domain indices such as rMSSD and pNN50 measures vagal influences. 16, 17 Low frequency component of the spectral analysis is considered either as a marker of sympathetic activation or of both vagal and sympathetic modulation. 16 The origin of the lower components of HRV is less understood. VLF may represent the influence of the thermoregulatory, 18 the renin-angiotensin systems 16 as well as of physical activity 19 or movement 20 while ULF and SDANN are clearly increased by physical activity or muscular movement. 19, 21, 22 Heart rate variability has been extensively studied in normal and abnormal clinical situations. Decrease of the lowest components of HRV is an independent prognostic factors after acute myocardial infarction. 23, 24 There are few data on HRV values in carriers of channelopathies. Two studies have found differences in autonomic modulation in the congenital long QT syndrome, with a lower sympathetic activity. 25, 26 A third study found no modification in HRV parameters in the different forms of the congenital long QT syndrome. 27 Ultra low frequency was not measured in any of those studies. In idiopathic VF, time domain HRV was not found modified compared to controls. 28 In the BS, HRV has been evaluated in few studies and there are no data available on SDANN or ULF. Unchanged HRV was found in carriers of SCN5A mutation with features of both long QT syndrome and BS (1795insD). 29 An increased sympathetic activity was observed before VF attacks in a patient with an electrical storm. 30 Lastly, an attenuated vagal tone was found in one asymptomatic patient. 31 In the present work, unlike the study hypothesis, we have not found differences in the HRV parameters assessing autonomic nervous system activity between symptomatic versus asymptomatic patient. We have found in symptomatic BS, a nocturnal reduction of the parameters 10 (71) 12 (67) a BS: Brugada Syndrome; n: number of cases; ST-SE: ST-segment elevation; ST-SE relative duration: relative duration of the ST-SE over the 24 h Holter monitoring. 
Loss of circadian modulation of QT rate-dependence in BS
QT rate-dependence as measured by QT/RR slope is greater during the diurnal period than during the nocturnal period in normal subjects. 33 Circadian modulation of the QT rate-dependence is thought to be related to the influence of the autonomic nervous system at the ventricular level. Nevertheless, it has been demonstrated that QT/RR is also under the influence of gender and aging. QT/RR is steeper in female 34 and decreases when age increases. 35 In normal volunteers close to the forth decade, which is the mean age of the study population, low circadian modulation of the QT rate-dependence is reported. 35 Therefore, loss of circadian modulation of QT/RR observed here may be related to a defective ventricular repolarization control but also explained by the mean age of the study population.
Holter ST-SE in BS
Relative duration of ST-SE was not longer in symptomatic patients than in asymptomatic patients and was not correlated to the presence of a typical spontaneous BS-ECG. The presence of a typical spontaneous BS-ECG which is recognized as a marker of risk in the BS did not depend on the relative extent of ST-SE during Holter monitoring. Thus patients with typical spontaneous BS-ECG and patients with Brugada-compatible ECG could not be differentiated by the extent of ST-SE. However, from a practical point of view, ST-segment study during Holter monitoring may be useful when revealing the typical pattern in relatives or subjects with suspicious 12-lead ECG (Fig. 2) .
Risk markers in BS
A typical spontaneous BS-ECG versus a drug-induced BS-ECG is an accepted marker of arrhythmic event. 11, 15 The event rate was 14% (16/111) in presence of a typical spontaneous BS-ECG in asymptomatic individuals followed during a 27-month follow-up. 11 Accuracy of electrophysiologic study to predict outcome in patients with BS is debated. For Priori 15 and Kanda 36 programmed ventricular stimulation has low if no value predicting recurrence of arrhythmic events in symptomatic patients with BS. In contrast, in the largest series concerning the specific outcome of asymptomatic patients with BS, 37 the overall accuracy was 70.5% and the negative predictive value was 99%. It has been suggested that the differences may result in the number and categories of subjects integrated in each study 38 as well as in the various protocols used for the programmed ventricular stimulation. 39 No other markers were found in this last study except a trend toward a better outcome in female versus male. 11 Recently, attention has been focused on the importance of ventricular late potentials in identifying patients at risk. 40 Multivariate regression analysis including late potential, T-wave alternans and QT-interval dispersion showed that the presence of late potential had the most significant correlation with the occurrence of arrhythmic event. However, multivariate analysis did not include programmed ventricular stimulation or the presence of a typical spontaneous BS-ECG.
In the present study, we found as in previous reports, that VT/VF inducibility and a typical spontaneous BS-ECG were markers of risk in BS patients. We noticed that a decreased nocturnal SDANN was independently associated with arrhythmic events and that there was no clear evidence of a defective autonomic nervous activity based on Holter analysis in symptomatic BS patients.
Methodological considerations
This study is a case-control study. Despite the absence of matching, control asymptomatic patients were comparable to symptomatic patients for the main clinical variables. Nevertheless, a difference in the amount of familial BS was evidenced and may have influenced the results.
Due to a large number of testing made in this study, false positive result may have been found. Nevertheless, the fact that concordant results are observed in two variables with similar signification (nocturnal SDANN and nocturnal ULF) argues against such an error-type.
The small number of recurrence of arrhythmic events in symptomatic patients and the short follow-up after Holter recordings were not appropriate for using the Cox regression model. Therefore, the preliminary data reported here should be confirmed in a prospective study with an adequate follow-up. As well, for ST-SE systematic analysis on Holter monitoring, the electrodes should be carefully positioned in order to systematically record suitable right precordial leads.
